Zevra Therapeutics Rockets On Takeover Buzz After Collegium’s Financing Shortfall!

Zevra Therapeutics jumped on renewed takeover chatter after a Betaville alert linked Collegium to a stalled bid. Strong MIPLYFFA growth, cash from voucher sale, & rare-disease pipeline fuel the buzz.

SiriusPoint Sells ArmadaCare for $250M – Here’s Why Ambac Is All In!

SiriusPoint sells ArmadaCare to Ambac for $250M, advancing its specialty focus. Ambac gains a growth foothold in health benefits, with the deal expected to add $220–$230M in pre-tax gains.

Harrow’s MELT Acquisition Could Disrupt IV Sedation—But Is It The Hottest Pharma Small-Cap Buy?

Harrow Inc. targets Melt Pharma buyout to expand sedation portfolio with MELT-300, a sublingual non-IV sedative, aiming for U.S. launch and global partnerships while diversifying beyond ophthalmics.

3D Systems Hands Over Its Software Crown Jewels — What Hubb Global Gains

3D Systems is divesting Oqton MOS and 3DXpert to Hubb Global Holdings, aiming to sharpen focus on polymers while Hubb explores monetization and synergy with its software assets.

Reddit Tumbles Again as ChatGPT Citations Shrink

Reddit (RDDT) extended its decline for a second straight day on Wednesday, falling more than 10% after new data showed its content appearing far less often in responses from OpenAI’s ChatGPT.

Stock Market Today: Investors Face Uncertainty as Shutdown, Tariffs, and Fed Policy Collide

US stocks struggled on Wednesday after Washington entered its first government shutdown in seven years, raising concerns over the economic fallout just as a closely watched jobs report delivered a negative surprise.

Semler Scientific’s Quiet Cash Machine Is Fueling A Bitcoin Empire—The Real Reason Behind Strive’s 210% Buyout Offer!

Semler Scientific to merge with Strive Asset Management in all-stock deal at a 210% premium. Shareholders get 21.05 Strive shares each as firms form a major Bitcoin treasury player with 10,900+ BTC.
You've successfully subscribed to WallSt Focus
Great! Next, complete checkout for full access to WallSt Focus
Welcome back! You've successfully signed in.
Unable to sign you in. Please try again.
Success! Your account is fully activated, you now have access to all content.
Error! Stripe checkout failed.
Success! Your billing info is updated.
Error! Billing info update failed.